Evaluation of STARgraft-2 for Hemodialysis Access

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

October 31, 2023

Conditions
End Stage Renal Disease
Interventions
DEVICE

Implant of STARgraft-2 shunt in the upper arm and subsequent use for hemodialysis access

After healing from the surgical procedure the graft will be routinely cannulated for hemodialysis sessions. Periodic evaluations of blood flow by ultrasound imaging will be made over the study period. Established standards of care will be followed as needed to maintain dialysis function.

Trial Locations (1)

Unknown

Italian Hospital, Asunción

Sponsors
All Listed Sponsors
lead

Healionics Corporation

INDUSTRY